These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 27008692)
41. Validation of amino-acids measurement in dried blood spot by FIA-MS/MS for PKU management. Bruno C; Dufour-Rainfray D; Patin F; Vourc'h P; Guilloteau D; Maillot F; Labarthe F; Tardieu M; Andres CR; Emond P; Blasco H Clin Biochem; 2016 Sep; 49(13-14):1047-50. PubMed ID: 27450222 [TBL] [Abstract][Full Text] [Related]
42. Effect of diet on plasma total antioxidant status in phenylketonuric patients. Schulpis KH; Tsakiris S; Karikas GA; Moukas M; Behrakis P Eur J Clin Nutr; 2003 Feb; 57(2):383-7. PubMed ID: 12571675 [TBL] [Abstract][Full Text] [Related]
43. Obese subjects have significantly higher serum prooxidantantioxidant balance values compared to normal-weight subjects. Razavi A; Baghshani MR; Ardabili HM; Andalibi MS; Rahsepar AA; Moohebati M; Nematy M; Tavallaie S; Mousavi S; Akhlaghi S; Ghayour-Mobarhan M; Ferns G Clin Lab; 2013; 59(3-4):257-61. PubMed ID: 23724612 [TBL] [Abstract][Full Text] [Related]
44. Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria. Sharman R; Sullivan K; Young R; McGill J Clin Genet; 2009 Feb; 75(2):169-74. PubMed ID: 19215250 [TBL] [Abstract][Full Text] [Related]
45. Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients. Sitta A; Manfredini V; Biasi L; Treméa R; Schwartz IV; Wajner M; Vargas CR Mutat Res; 2009; 679(1-2):13-6. PubMed ID: 19665577 [TBL] [Abstract][Full Text] [Related]
46. [Pathogenetic mechanisms in phenylketonuria: disorders affecting the metabolism of neurotransmitters and the antioxidant system]. Ormazábal A; Artuch R; Vilaseca MA; García-Cazorla A; Campistol J Rev Neurol; 2004 Nov 16-30; 39(10):956-61. PubMed ID: 15573314 [TBL] [Abstract][Full Text] [Related]
47. Reduced acetylcholinesterase activity in erythrocyte membranes from patients with phenylketonuria. Tsakiris S; Schulpis KH; Tjamouranis J; Michelakakis H; Karikas GA Clin Biochem; 2002 Nov; 35(8):615-9. PubMed ID: 12498995 [TBL] [Abstract][Full Text] [Related]
48. Urinary biomarkers of oxidative stress and plasmatic inflammatory profile in phenylketonuric treated patients. Deon M; Sitta A; Faverzani JL; Guerreiro GB; Donida B; Marchetti DP; Mescka CP; Ribas GS; Coitinho AS; Wajner M; Vargas CR Int J Dev Neurosci; 2015 Dec; 47(Pt B):259-65. PubMed ID: 26456498 [TBL] [Abstract][Full Text] [Related]
49. The effects of sapropterin on urinary monoamine metabolites in phenylketonuria. Douglas TD; Jinnah HA; Bernhard D; Singh RH Mol Genet Metab; 2013 Jul; 109(3):243-50. PubMed ID: 23712020 [TBL] [Abstract][Full Text] [Related]
50. Plasma phenylalanine concentrations are associated with hepatic iron content in a murine model for phenylketonuria. Gropper SS; Yannicelli S; White BD; Medeiros DM Mol Genet Metab; 2004 May; 82(1):76-82. PubMed ID: 15110326 [TBL] [Abstract][Full Text] [Related]
51. L-Phenylalanine concentration in blood of phenylketonuria patients: a modified enzyme colorimetric assay compared with amino acid analysis, tandem mass spectrometry, and HPLC methods. De Silva V; Oldham CD; May SW Clin Chem Lab Med; 2010 Sep; 48(9):1271-9. PubMed ID: 20604724 [TBL] [Abstract][Full Text] [Related]
52. Morning preprandial plasma ghrelin and catecholamine concentrations in patients with phenylketonuria and normal controls: evidence for catecholamine-mediated ghrelin regulation. Schulpis KH; Papassotiriou I; Vounatsou M; Karikas GA; Tsakiris S; Chrousos GP J Clin Endocrinol Metab; 2004 Aug; 89(8):3983-7. PubMed ID: 15292337 [TBL] [Abstract][Full Text] [Related]
53. Demethylation of the promoter region of GPX3 in a newborn with classical phenylketonuria. Item CB; Escueta S; Schanzer A; Farhadi S; Metz T; Zeyda M; Möslinger D; Greber-Platzer S; Konstantopoulou V Clin Biochem; 2017 Feb; 50(3):159-161. PubMed ID: 27742442 [TBL] [Abstract][Full Text] [Related]
54. Studies on the experimental phenylketonuria in rats. Iijima S; Ishii A; Miyakoshi T; Odaira T; Musha M Tohoku J Exp Med; 1975 Oct; 117(2):167-78. PubMed ID: 1209606 [TBL] [Abstract][Full Text] [Related]
55. A GC/MS-based metabolomic approach for reliable diagnosis of phenylketonuria. Xiong X; Sheng X; Liu D; Zeng T; Peng Y; Wang Y Anal Bioanal Chem; 2015 Nov; 407(29):8825-33. PubMed ID: 26410738 [TBL] [Abstract][Full Text] [Related]